Aurora Therapeutics Launches to Realize the Potential of Personalized Gene Editing for Millions of Patients with Rare Diseases
- Leveraging modular gene editors and new regulatory pathways, Aurora will develop and commercialize therapies that can be rapidly tailored to many rare variants - - Founded by CRISPR pioneers Jennifer Doudna and Fyodor Urnov to scale up impact of gen...